Trial · NCT00499863
Adverse events20
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 20
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Nausea | Gastrointestinal disorders | Methylphenidate Transdermal System | 14 | 145 | 14 |
| other | Nausea | Gastrointestinal disorders | Placebo (PTS) | 2 | 72 | 3 |
| other | Upper respiratory tract infection | Infections and infestations | Methylphenidate Transdermal System | 15 | 145 | 15 |
| other | Upper respiratory tract infection | Infections and infestations | Placebo (PTS) | 7 | 72 | 7 |
| other | Weight decreased | Investigations | Methylphenidate Transdermal System | 8 | 145 | 9 |
| other | Weight decreased | Investigations | Placebo (PTS) | 1 | 72 | 1 |
| other | Decreased appetite | Metabolism and nutrition disorders | Methylphenidate Transdermal System | 37 | 145 | 41 |
| other | Decreased appetite | Metabolism and nutrition disorders | Placebo (PTS) | 1 | 72 | 1 |
| other | Dizziness | Nervous system disorders | Methylphenidate Transdermal System | 8 | 145 | 8 |
| other | Dizziness | Nervous system disorders | Placebo (PTS) | 1 | 72 | 1 |
| other | Headache | Nervous system disorders | Methylphenidate Transdermal System | 18 | 145 | 20 |
| other | Headache | Nervous system disorders | Placebo (PTS) | 9 | 72 | 9 |
| other | Insomnia | Psychiatric disorders | Methylphenidate Transdermal System | 9 | 145 | 11 |
| other | Insomnia | Psychiatric disorders | Placebo (PTS) | 2 | 72 | 2 |
| other | Irritability | Psychiatric disorders | Methylphenidate Transdermal System | 16 | 145 | 16 |
| other | Irritability | Psychiatric disorders | Placebo (PTS) | 5 | 72 | 5 |
| serious | syncope | Nervous system disorders | Methylphenidate Transdermal System | 1 | 145 | 2 |
| serious | syncope | Nervous system disorders | Placebo (PTS) | 0 | 72 | 0 |
| serious | negativism | Psychiatric disorders | Methylphenidate Transdermal System | 0 | 145 | 0 |
| serious | negativism | Psychiatric disorders | Placebo (PTS) | 1 | 72 | 1 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00499863/events